Last updated on January 2019

Genomic Testing and Resulting Medical Decisions


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Cancer of Unknown Origin | HEPATIC NEOPLASM | Colorectal Cancer | Lung Neoplasm | bladder cancer | Cancer Refractory | Uterine Cancer | head and neck cancer | Gastric Cancer | Esophageal Cancer | Hematologic Malignancy | skin cancer | Malignant neoplasm of kidney | Breast Cancer | Cervical Cancer
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

This registry will include cancer patients for which broad genomic profiling is indicated as assessed by the medical need and as deemed appropriate by the physician, for example

  • cancer with high mutational load and suspicion of regular or frequent formation of neoantigens
  • skin, lung, stomach, esophagus, colorectum, bladder, uterus, cervix, liver, head and neck, kidney, breast
  • lymphoma B-cell
  • any other neoplastic disease where molecular targeting is performed but treatment fails
  • cancer of unknown primary origin (CUP)
  • planned or already carried out comprehensive genomic testing as of Jan 1, 2016 note: this registry will not initially register patients who are tested for only 1-5 mutations by conventional means, but patients undergoing genomic profiling based on NGS)
  • a patients signed informed consent
  • Patients 18 years of age

Exclusion Criteria:

  • Due to the non-interventional design of the registry there are no specific exclusion criteria.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.